Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.23 EUR | -0.27% | -3.49% | -42.81% |
Dec. 03 | BAYER AG : JP Morgan reaffirms its Neutral rating | ZD |
Dec. 03 | ZBD Pharma Gets China Approval for Antibacterial Injection | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
20 | |||||||||
27 | |||||||||
24 | |||||||||
23 | |||||||||
28 | |||||||||
25 | |||||||||
18 | |||||||||
19 | |||||||||
19 | |||||||||
26 | |||||||||
23 | |||||||||
21 | |||||||||
21 | |||||||||
28 | |||||||||
15 | |||||||||
18 | |||||||||
18 | |||||||||
17 | |||||||||
17 | |||||||||
Average | 21 | ||||||||
Weighted average by Cap. | 23 |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector revisions